Related Experiment Video
Updated: Jul 17, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
[Viral hepatitis during pregnancy]
Krzysztof Gutkowski1, Dorota Gutkowska, Jacek Lepiech
1Oddział Chorób Wewnetrznych, Szpitala Ministerstwa Spraw Wewnqtrznych i Administracji, Rzeszowie. kgutski@intertele.pl
Ginekologia Polska
|January 16, 2007
Summary
Viral hepatitis during pregnancy poses risks to mothers and fetuses. This review covers prevention, epidemiology, and treatments for viral hepatitis A through G, including lamivudine therapy to prevent vertical transmission.
Area of Science:
- Hepatology
- Virology
- Obstetrics
Context:
- Viral hepatitis is a significant concern during pregnancy.
- Effective vaccines for most hepatotropic viruses are lacking, limiting prevention.
- Pregnancy increases the risk of infection for both mother and fetus.
Purpose:
- To review the epidemiology, prophylaxis, and treatment of viral hepatitis A, B, C, D, E, and G in pregnant women.
- To discuss the potential risks associated with viral hepatitis during pregnancy.
- To examine recent findings on lamivudine therapy for preventing vertical transmission.
Summary:
- This paper discusses viral hepatitis in pregnancy, covering types A-G.
- It explores epidemiological data, preventive strategies, and treatment options.
- Recent advancements, including lamivudine therapy to prevent mother-to-child transmission, are reviewed.
- Rarely diagnosed viral hepatitis from herpes simplex virus, cytomegalovirus, Epstein-Barr virus, and adenoviruses are also characterized.
Impact:
- Provides a comprehensive overview of viral hepatitis management in pregnancy.
- Highlights the importance of understanding risks and available treatments.
- Informs clinical practice regarding prevention of vertical transmission and management of diverse viral hepatitis cases.
Related Concept Videos
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...